The Global Medical Director, Urothelial Cancer reports to a Global Medical Strategy Lead (GMSL), Urothelial Cancer.
The role primarily provides support in developing and executing the medical plan and associated tactics. The role is also key in preparing information and materials for Global Medical Affairs Teams (GMAT) and the Global Product Team (GPT) endorsement as needed.
They are responsible, at the product/asset level, for the oversight of medical deliverables in association with the medical plan and overall brand strategy commercial. They are a key interface between Pfizer oncology and Pfizer’s broader organization supporting cross functional work with Clinical Trial Study Teams, including, Safety, Oncology Regulatory Strategy, Global Value and Access (and other functions as needed).
RESPONSIBILITIES:
Responsible for providing support in advancing key deliverables focused on advancing communication around disease state, therapeutic management, and overall product value; Includes, but not limited to medical affairs plans, scientific communication platforms, engagement plans, access initiatives and trial support
Supports lightspeed clinical trial execution through working collaboratively with core medical and development functions to assist with Key Opinion Leader (KOL)/Investigator identification and site education and support
Connects with Clinical Trial Study teams to advance key deliverables end to end, from study concept through study data read out and closure
Leverages KOL network and insights to inform and adapt medical affairs plans, development plans and brand plans
Collaborates cross functionally to prepare and drive scientific engagement plans as well as report findings and trends from engagements back to key internal stakeholders
Builds relationships with KOLs and other external stakeholders to help gather medical insights to optimize medical and development strategy
Supports the development of and execution of an integrated evidence plans
Captures, catalogs, and triages prioritized medical insights and unmet needs from regulators, trial PIs/KOLs, Patients, and other R&D stakeholders
Understands the needs of other health system stakeholders (e.g., HTAs, payers, providers) as identified by GMAT, and integrated evidence generation teams
Identifies appropriate research methods and prioritization of evidence generation activities for development related priorities (incl. R&D-facing RWE)
Assists in developing areas of interest and noninterest for Investigator Sponsored Research studies and support the GMSL and regional colleagues in preparing concepts for review and potential endorsement
Support these GMSL/Launch lead in developing support for early patient access through sanctioned programs where there is a need to bridge approval and reimbursement, assess implications of Pre-approval Access Programs on the clinical development plan and regulatory status. Supports TA lead/Launch lead in developing. Supports assessment of required framework / guardrails for potential programs
Contributes to the Scientific Communications Platform (SCP) to support aligned information/messages related to disease state / landscape, MOA and key data points
Aligns with GMSL and publication/content leaders in CoE to introduce evolving evidence from clinical studies, into the communication framework and internal and external communication plans
Ensures the medicine-level SCP is aligned to the broader tumor and/or modality scientific narrative and overall brand narrative
Supports establishment of Publications Plan based on upcoming data readouts from R&D driven programs, including evidence / meta-analyses designed to address regulatory / safety topics. Support the Strategy/launch lead in preparing for and obtaining endorsement by study team and GPTs
Works closely with clinical study teams during data readouts to determine key messages and publication content (aligned to overall publication strategy and Scientific Communications Platform) and works with CoE on execution. Ensures the Publications Plan is aligned with the Scientific Communications Platform
Assesses and identifies internal and external education gaps in collaboration with CoEs focused on advancing internal and external understanding of disease state awareness and therapeutic landscape. Ensures educational activities and proposals support the overarching medical and brand plans
Collaborates with Pfizer Oncology Medical Affairs functions to identify key priorities for data communication at scientific congresses; review identified materials to ensure medical accuracy.
Provides medical support and expertise to the patient advocacy organization to advance our mission of providing an equitable, patient-centric experience for of those undergoing cancer treatment
Evaluates innovation platforms and identifies opportunities to create efficiency and improved outcomes across core medical affairs activities. Collaborates with key stakeholders to leverage innovation and expertise of medical
QUALIFICATIONS:
MD with demonstrated experience and understanding of biopharmaceutical drug development.
Oncology clinical development or Medical Affairs experience needed; relevant academic and clinical Oncology experience will be considered.
5+ years of progressive experience in global medical affairs and/or clinical development in a pharmaceutical or biotech organization.
Knowledge of the Oncology competitive landscape, stakeholder community and demonstrated deep expertise of their TA and medicines they are supporting.
Excellent interpersonal and communication skills. Ability to think strategically with a collaborative mindset and a proven track record of working effectively in diverse teams involving complex multi-functional disciplines.
Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers, develop and coach others, oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact.
Work Location Assignment: Hybrid - must be onsite an average of 2.5 days per week
Relocation assistance may be available based on business needs and/or eligibility.
Sunshine Act
Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and regulations require Pfizer to provide government agencies with information such as a health care provider’s name, address and the type of payments or other value received, generally for public disclosure. Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act. Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government. If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative.
EEO & Employment Eligibility
Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E-Verify employer. This position requires permanent work authorization in the United States.
Pfizer endeavors to make www.pfizer.com/careers accessible to all users. If you would like to contact us regarding the accessibility of our website or need assistance completing the application process and/or interviewing, please email disabilityrecruitment@pfizer.com. This is to be used solely for accommodation requests with respect to the accessibility of our website, online application process and/or interviewing. Requests for any other reason will not be returned.